NCT05488119

Brief Summary

Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) improve representation of youth in the literature, (2) address the gap in knowledge of barriers and promoters in youth, and (3) identify and address factors associated with diabetes technology uptake and utilization.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Apr 2025Jun 2026

First Submitted

Initial submission to the registry

July 26, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 4, 2022

Completed
2.7 years until next milestone

Study Start

First participant enrolled

April 15, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

April 25, 2025

Status Verified

April 1, 2024

Enrollment Period

1.2 years

First QC Date

July 26, 2022

Last Update Submit

April 22, 2025

Conditions

Keywords

Diabetes TechnologyPediatric Type 1 Diabetes

Outcome Measures

Primary Outcomes (3)

  • Interviews with you on your feedback on the intervention

    The investigators will ask you questions in a 30-minute interview at the end of the four-week intervention. The investigators will as your feedback on ways the intervention could be more effective and what changes can be made to the intervention so that it is most effective. The investigators will ask you if you are likely to change your diabetes management after completing the intervention.

    Upon completion of intervention on week 4

  • Survey questions on your feedback on the intervention

    The investigators will ask you questions in a feedback survey at the end of the four-week intervention. These questions will be developed by the investigators and will ask you ways the intervention could be more effective and what changes can be made to the intervention so that it is most effective. Example questions of what the investigators plan to ask in the survey include: * Was the study explained appropriately? * Was it logistically easy to participate in the study? How could it have improved? * What parts of the intervention were most helpful? * What parts could be cut? * What parts need to be added? * Are there certain types of people who are likely to do better with this intervention?

    Upon completion of intervention on week 4

  • Tracking people who complete the study

    The investigators will also keep track of who enrolled in the study and track how many people completed the intervention.

    Through study completion, an average of one year

Secondary Outcomes (1)

  • Changes in diabetes technology usage

    At the start of the study and upon completion of intervention on week 4

Study Arms (1)

Pilot Intervention

EXPERIMENTAL

The design for this phase is a prospective pilot study. The intervention will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. The investigators will also evaluate youth diabetes management and technology use. Families will be compensated in a stepwise fashion. Virtual delivery of the pilot intervention will facilitate national recruitment and allow for recruitment during the pandemic or any ensuing limitations to in-person recruitment.

Behavioral: Intervention to increase diabetes technology uptake

Interventions

The design for this phase is a prospective pilot study. The intervention modules will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. The investigators will also evaluate youth diabetes management and technology use. Families will be compensated in a stepwise fashion. Virtual delivery of the pilot intervention will facilitate national recruitment and allow for recruitment during the pandemic or any ensuing limitations to in-person recruitment. I will recruit 20 families or providers to participate in the delivery of the pilot intervention designed in Phase 1 of the study via a stakeholder advisory board.

Pilot Intervention

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The investigators will include youth aged 12-21 years in this study. The lower limit of 12 years was selected as this is the age when youth are able to understand and reflect on the topics discussed in the survey measures and focus groups. The upper limit of 21 years was selected as this is the upper limit of public payer coverage (for example, California Children's Services). This aim focuses specifically on the family (youth and parent/guardian) factors that determine diabetes technology use and thus requires that youth are living with their parent/guardian in order to be included in this study. For youth under 18, the investigators will obtain both parental permission and youth assent to participate in the study. For those older than 18, the investigators will obtain consent from the youth alone.

You may not qualify if:

  • Diabetes diagnosis in youth other than type 1
  • T1D youth less than the age of 12 or older than 21
  • non-public payer insurance
  • caregivers not living with the youth with type 1 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 26, 2022

First Posted

August 4, 2022

Study Start

April 15, 2025

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

April 25, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations